Related references
Note: Only part of the references are listed.Updates and novel treatments in urothelial carcinoma
Kirollos S. Hanna
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Grading of Urothelial Carcinoma and The New World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016
Eva M. Comperat et al.
EUROPEAN UROLOGY FOCUS (2019)
Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines
Eva Sipos et al.
ONCOTARGETS AND THERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer
Joerg B. Engel et al.
CURRENT DRUG TARGETS (2016)
Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 (AEZS-108)
Karoly Szepeshazi et al.
Oncotarget (2015)
Advanced bladder cancer: New agents and new approaches. A review
Andrea Volpe et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Emerging therapies for urothelial cancer
Cesar Serrano et al.
CANCER TREATMENT REVIEWS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Current treatment of metastatic bladder cancer and future directions
Amy Q. Lei et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Receptors for Luteinizing Hormone-Releasing Hormone (LHRH) in Benign Prostatic Hyperplasia (BPH) as Potential Molecular Targets for Therapy With LHRH Antagonist Cetrorelix
Bernadett Rozsa et al.
PROSTATE (2011)
Pathobiology and Chemoprevention of Bladder Cancer
Takuji Tanaka et al.
JOURNAL OF ONCOLOGY (2011)
Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors
Guenter Emons et al.
GYNECOLOGIC ONCOLOGY (2010)
Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder
Stephen A. Boorjian et al.
ENDOCRINE-RELATED CANCER (2009)
Expression of mRNA for human type-I LHRH receptor transcript forms in human benign prostatic hyperplasia
Bernadett Rozsa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
Keith Syson Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Bladder cancer subtypes defined by genomic alterations
Margaret A. Knowles
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2008)
Gonadotropin-releasing hormone (GnRH) and GnRH receptor in bladder cancer epithelia and GnRH effect on bladder cancer cell proliferation
Jong Yoon Bahk et al.
UROLOGIA INTERNATIONALIS (2008)
Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone
Joerg B. Engel et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Luteinizing hormone and follicle-stimulating hormone receptors and their transcribed genes (mRNA) are present in the lower urinary tract of intact male and female dogs
S. Ponglowhapan et al.
THERIOGENOLOGY (2007)
Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues
G Keller et al.
CLINICAL CANCER RESEARCH (2005)
Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-1I, and their receptors in humans
CK Cheng et al.
ENDOCRINE REVIEWS (2005)
Gonadotropin-releasing hormone receptors
RP Millar et al.
ENDOCRINE REVIEWS (2004)
Chemotherapy targeted to cancers through tumoral hormone receptors
AV Schally et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
ENDOCRINE REVIEWS (2003)
Hypothalamic hormones and cancer
AV Schally et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2001)
High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers
G Halmos et al.
JOURNAL OF UROLOGY (2000)
Share Paper
